Vera Therapeutics, Inc.

VERA · Nasdaq · SIC 2834: Pharmaceutical Preparations
97
SEC Filings

Business Summary

1 Item 1A. Risk Factors 41 Item 1B. Unresolved Staff Comments 91 Item 1C. Cybersecurity 91 Item 2. Properties 93 Item 3. Legal Proceedings 93 Item 4. Mine Safety Disclosures 93 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 94 Item 6. Reserved 95 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 96 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 103 Item 8. ...

Next Earnings

Q2 FY2026 — expected 2026-08-05

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVERAdiscussed_in_filing Cybersecurity
topic_mentionVERAdiscussed_in_filing Cybersecurity
topic_mentionVERAdiscussed_in_filing Cybersecurity
topic_mentionVERAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-077442EDGAR110K words
2025-02-282024-12-310000950170-25-029969EDGAR—
2024-03-272023-12-310000950170-24-036729EDGAR—
2023-03-282022-12-310000950170-23-010288EDGAR—
2022-03-282021-12-310000950170-22-004701EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266881EDGAR68K words
2025-08-052025-06-300000950170-25-103022EDGAR—
2025-05-072025-03-310000950170-25-064733EDGAR—
2024-11-072024-09-300000950170-24-123239EDGAR—
2024-08-082024-06-300000950170-24-094108EDGAR—
2024-05-102024-03-310000950170-24-057292EDGAR—
2023-11-092023-09-300000950170-23-062139EDGAR—
2023-08-102023-06-300000950170-23-041399EDGAR—
2023-05-112023-03-310000950170-23-021335EDGAR—
2022-11-092022-09-300000950170-22-023932EDGAR—
2022-08-102022-06-300000950170-22-016498EDGAR—
2022-05-162022-03-310000950170-22-010094EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-098783EDGAR1K words
2026-02-260001193125-26-073421EDGAR—
2025-12-180001193125-25-323298EDGAR—
2025-12-100001193125-25-314430EDGAR—
2025-11-260001193125-25-300647EDGAR—
2025-11-060001193125-25-268331EDGAR—
2025-11-050001193125-25-265799EDGAR—
2025-08-050001193125-25-173591EDGAR—
2025-08-050000950170-25-102399EDGAR—
2025-06-030001193125-25-133730EDGAR—

97 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001831828
TickerVERA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 653bfaf7cb27231cd514e60e48b340294d4a0d9716260e673c151d49505d0002
parent: c7dc1c59db751e933969ddbaba0b9f832afe1066975690e1db91d73075b9957c
content hash: 953434b79bfa174734cde67766136afa7a31e10edd1130b21c60b48a71681672
signed: 2026-04-13T04:48:04.183Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf